AbCellera Biologics Inc vs Arista Networks Inc — how do they compare? AbCellera Biologics Inc trades at $9.22 (market cap $2.99B), while Arista Networks Inc trades at $201.44 (market cap $249.53B). The key difference: Arista Networks Inc is far larger — about 83.5× AbCellera Biologics Inc's market cap, and Arista Networks Inc is trading nearer its 52-week high, AbCellera Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ABCL | ANET | |
|---|---|---|
Market Cap | $2.99B | $249.53B |
Sector | Health | Technology |
52-Week High | $9.76 | $197.85 |
52-Week Low | $2.78 | $116.13 |
Enterprise Value | $2.58B | $236.19B |
Trailing returns across standard periods
Latest headlines on both assets
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →Arista Networks is a software and hardware provider for the networking solutions sector. Operating as one business unit, software, switching, and router products are targeted for high-performance networking applications, while service revenue comes from technical support. Customer markets include data centers, enterprises, service providers, and campuses. The company is headquartered in Santa Clara, California, and generates most of its revenue in the Americas.
Read more on ANET →